These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

914 related articles for article (PubMed ID: 29428311)

  • 1. Impact of cancer treatment on risk of infertility and diminished ovarian reserve in women with polycystic ovary syndrome.
    Shandley LM; Fothergill A; Spencer JB; Mertens AC; Cottrell HN; Howards PP
    Fertil Steril; 2018 Mar; 109(3):516-525.e1. PubMed ID: 29428311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of tamoxifen therapy on fertility in breast cancer survivors.
    Shandley LM; Spencer JB; Fothergill A; Mertens AC; Manatunga A; Paplomata E; Howards PP
    Fertil Steril; 2017 Jan; 107(1):243-252.e5. PubMed ID: 27887709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential rate in decline in ovarian reserve markers in women with polycystic ovary syndrome compared with control subjects: results of a longitudinal study.
    Ahmad AK; Kao CN; Quinn M; Lenhart N; Rosen M; Cedars MI; Huddleston H
    Fertil Steril; 2018 Mar; 109(3):526-531. PubMed ID: 29428308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P; Dilgil M; Gudi A; Shah A; Akwaa C; Homburg R
    Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility preservation in childhood and adolescent female tumor survivors.
    Filippi F; Meazza C; Somigliana E; Podda M; Dallagiovanna C; Massimino M; Raspagliesi F; Terenziani M
    Fertil Steril; 2021 Oct; 116(4):1087-1095. PubMed ID: 34238574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility.
    Greenwood EA; Cedars MI; Santoro N; Eisenberg E; Kao CN; Haisenleder DJ; Diamond MP; Huddleston HG;
    Fertil Steril; 2017 Dec; 108(6):1070-1077. PubMed ID: 29202959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers of ovarian reserve in women with polycystic ovary syndrome.
    Huddleston HG
    Semin Reprod Med; 2013 Nov; 31(6):452-61. PubMed ID: 24101226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infertile women below the age of 40 have similar anti-Müllerian hormone levels and antral follicle count compared with women of the same age with no history of infertility.
    Hvidman HW; Bentzen JG; Thuesen LL; Lauritsen MP; Forman JL; Loft A; Pinborg A; Nyboe Andersen A
    Hum Reprod; 2016 May; 31(5):1034-45. PubMed ID: 26965431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycystic ovarian morphology and the diagnosis of polycystic ovary syndrome: redefining threshold levels for follicle count and serum anti-Müllerian hormone using cluster analysis.
    Lie Fong S; Laven JSE; Duhamel A; Dewailly D
    Hum Reprod; 2017 Aug; 32(8):1723-1731. PubMed ID: 28854584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian morphology assessed by magnetic resonance imaging in women with and without polycystic ovary syndrome and associations with antimüllerian hormone, free testosterone, and glucose disposal rate.
    Leonhardt H; Hellström M; Gull B; Lind AK; Nilsson L; Janson PO; Stener-Victorin E
    Fertil Steril; 2014 Jun; 101(6):1747-56.e1-3. PubMed ID: 24661732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome.
    Cui Y; Shi Y; Cui L; Han T; Gao X; Chen ZJ
    Fertil Steril; 2014 Jul; 102(1):230-236.e2. PubMed ID: 24746743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes.
    Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B
    Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling.
    Weerakiet S; Lertvikool S; Tingthanatikul Y; Wansumrith S; Leelaphiwat S; Jultanmas R
    Gynecol Endocrinol; 2007; 23(8):455-60. PubMed ID: 17852413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A patient-specific model combining antimüllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders.
    Vagios S; James KE; Sacha CR; Hsu JY; Dimitriadis I; Bormann CL; Souter I
    Fertil Steril; 2021 Jan; 115(1):229-237. PubMed ID: 33077236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of cancer therapies on ovarian reserve.
    Gracia CR; Sammel MD; Freeman E; Prewitt M; Carlson C; Ray A; Vance A; Ginsberg JP
    Fertil Steril; 2012 Jan; 97(1):134-40.e1. PubMed ID: 22137491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
    Feldman RA; O'Neill K; Butts SF; Dokras A
    Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian reserve after treatment with alkylating agents during childhood.
    Thomas-Teinturier C; Allodji RS; Svetlova E; Frey MA; Oberlin O; Millischer AE; Epelboin S; Decanter C; Pacquement H; Tabone MD; Sudour-Bonnange H; Baruchel A; Lahlou N; De Vathaire F
    Hum Reprod; 2015 Jun; 30(6):1437-46. PubMed ID: 25801499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10-year follow up of reproductive function in women treated for childhood cancer.
    Nielsen SN; Andersen AN; Schmidt KT; Rechnitzer C; Schmiegelow K; Bentzen JG; Larsen EC
    Reprod Biomed Online; 2013 Aug; 27(2):192-200. PubMed ID: 23768622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
    Tremellen K; Zander-Fox D
    Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relative importance of AMH and androgens changes with aging among non-obese women with polycystic ovary syndrome.
    Kushnir VA; Halevy N; Barad DH; Albertini DF; Gleicher N
    J Ovarian Res; 2015 Jul; 8():45. PubMed ID: 26156856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.